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Purpose: Increasing rates of clonal spread of fecal bla
TEM
 bacilli remains a huge concern to 
the community health with resultant high morbidity. The fecal carriage and clonal diversity of 
bla
TEM
 within the communities in Southwest Nigeria were surveyed.
Materials and methods: Enteric bacilli obtained from fresh  fecal samples randomly collected 
from community residents were biotyped and profiled for antibiotic susceptibility. Resistant 
strains were typed for beta-lactamase, extended-spectrum beta-lactamases (ESBL), AmpC and 
carbapenemase production while the R-plasmid carriage was detected and mating activities were 
examined. The presence of bla
TEM
 gene was assayed by PCR and its phylodiversity determined 
with 16sRNA genomic profiling.
Results: Escherichia coli have the highest (28.6%) occurrence rate and Pseudomonas aeruginosa 
(20.5%) showing significant resistance to beta-lactamase inhibitors (ampicillin, cefuroxime and 
cefotaxime), and high-level multidrug resistance of more than 15.2% rate to ampicillin, cefu-
roxime, ceftazidime, tetracycline and imipenem. E. coli and Klebsiella oxytoca, are the highest 
beta-lactamase, ESBL and AmpC producers encoded with high molecular weight R-plasmid 
(>11.0 kbp) and significant rate of conjugation and transformational activities. Only 2/14, 1/13 
and 1/6 ESBL-type of E. coli, K. oxytoca and Enterobacter cloaca, expressed bla
TEM
 gene, clus-
tering into five different phylodiverse groups with close genomic relatedness with other bacilli.
Conclusion: This is an indication of clonal dissemination of ESBL bla
TEM
 encoded enteric 
bacilli having high phylodiverse characteristics through fecal carriage in the Nigerian commu-
nity which requires public health education, food and environmental hygiene for its prevention.
Keywords: fecal, antibiotics, ESBL, R-plasmid, bla
TEM
Introduction
Increasing rates of clonal spread of beta-lactamase enteric bacilli remains a huge con-
cern to the community health with resultant high morbidity.1 Fecal colonization rates 
with extended-spectrum beta-lactamases (ESBL)-producing isolates are becoming 
prevalent in most communities with poor detection making implementing epidemio-
logical measures to curtail and control the spread remain unachievable. Nevertheless, 
the rate of fecal carriage among the community residents remains a public health 
problem which has not been addressed in a few national studies.
Fecal colonization with ESBL enteric bacilli is a risk factor for acquisition of severe 
gastrointestinal infection and a potential source of transmission among households.2,3 
With the uncontrolled use of antibiotics in most communities in Nigeria, acquisition 
of resistant strains considerably accelerates the selection pressure for diversification 
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and dissemination of mutant ESBL.4,5 Currently, the high 
prevalence of all bla genes in different communities is aided 
by continuous horizontal transfer of bla-encoded plasmids 
among clonally unrelated strains and also through local or 
international transfer which played a significant role in the 
persistence and spread of bla
TEM
 which was not commonly 
found.6,7 A number of TEM derivatives have been found to 
reduce affinity for beta-lactamase inhibitors showing negligible 
hydrolytic activity against the extended-spectrum cephalospo-
rins.8 However, interesting mutants of TEM beta-lactamases 
are now being recovered and could maintain the ability to 
hydrolyze third-generation cephalosporins which also dem-
onstrate inhibitor resistance called complex mutants of TEM. 
Plasmid-mediated horizontal transfer of bla
TEM-1
 genes has 
been demonstrated between poultry and humans with high 
conjugative mobility and transformational characteristics.8,9
Furthermore, the increasing rates of ESBL-expression 
among Gram-negative bacilli characterized with multiple 
clonal strains have risen substantially in several communi-
ties  causing focal outbreaks resulting in high mortality rate 
mostly in under-developed communities having  sporadic 
dissemination.10 Several infection-control measures focused 
on reducing this spread and deadly impact of its clonal 
transmission yielded little or no impact in many devel-
oping countries as a result of persistent spread of high 
level multi-antibiotic resistant strain.11 Recent mutational 
changes resulting in phylo-diverse beta-lactamase strains 
are an indication of antibiotic overuse,12 prolonged intestinal 
carriage13 and competitive interactions of various enteric 
strains within a host.14 The available therapeutic options 
for the treatment of ESBL-associated enteric infections 
are limited due to drug resistance conferred by the bla
TEM
, 
along with frequently observed co-resistance to various 
antibiotic classes, such as cephamycins, fluoroquinolones 
and aminoglycosides. A shift in the distribution of different 
ESBL types15 that show resistance to beta-lactam antibiotics 
among Gram-negative bacilli, usually confer resistance to 
carbapen ems and are also known to emerge as metallo-beta-
lactamases (MBL).16
The recent trend in the prevalence of enteric pathogens 
producing bla
TEM
 is associated with high rates of morbidity 
and health care costs.2 TEM gene mutations, which com-
monly spread with R-plasmids in enteric bacilli, sporadically 
reduce antibiotic efficacy.16 Therefore, this study was carried 
out to survey the fecal dissemination of bla
TEM
 encoded 
enteric bacilli with diverse phylogenetic characteristic within 
the studied community.
Materials and methods
sampling
Fresh fecal samples were randomly collected from  406 com-
munity residents who were attending the out-patient clinics. 
The fecal samples were transported and stored at 4°C in cold 
chain before analysis.  For this study, approval was obtained 
from the Ethics committee  of the Federal Medical Center, 
Abeokuta which also serves as referral center in Southwest, 
Nigeria (Ethical assign number: FMCA/470/HREC/02/2016) 
and also written informed consent from the individuals 
recruited for the study as they visited the out-patient clinics.
culture and biotyping
Enteric bacilli were isolated from fecal samples cultured on 
MacConkey Agar (Oxoid CM 516, UK) and Salmonella-
Shigella agar (Oxoid CM 543, UK), after incubation at 37°C 
for 18–24 hours. The enteric bacilli were selected according 
to their colony and cellular morphology and were biochemi-
cally characterized with API 24E test kit and interpreted 
using the manual for laboratory investigation of acute enteric 
infections.17
antimicrobial susceptibility testing
Susceptibility of the enteric bacteria isolates to various 
commonly used antibiotics was determined using disc dif-
fusion assay18 with the following panel; ampicillin (10 µg), 
amoxicillin/clavulanic acid (20 µg/10 µg), cefotaxime (30 
µg), ceftazidime (30 µg), imipenem (10 µg), cefuroxime (30 
µg), gentamicin (10 µg), ciprofloxacin (5 µg), tetracycline 
(30 µg) and azithromycin (5 µg). Briefly, 0.5 McFarlan tur-
bid broth of pure isolate was spread on Mueller Hinton agar 
and each antibiotic disc was placed at a distance of about 20 
mm from each other on the inoculated agar and incubated at 
37°C for 18–24 hours. The inhibition zones were measured 
and interpreted.19
Minimum inhibitory concentration (MIc) 
Resistant enteric bacilli were selected and their respective 
antibiotics inhibitory concentration was determined using the 
standard micro-dilution broth assay20 and the respective MIC 
of antibiotics to each isolate was determined for identification 
of multidrug resistant (MDR) enteric bacilli.
Phenotypic assay for beta-lactamase and 
esBl production
All MDR strains were tested for the production of beta-
lactamase using a modified method of starch-iodide paper 
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acidometric method.21 The overnight broth culture of beta-
lactamase producing isolates was assayed for ESBL types 
using the double disc method using ceftazidime (30 µg), 
cefotaxime (30 µg) discs, and amoxicillin-clavulanate (20/10 
µg).22
Inhibitor based test for ampc 
determination and hodge test 
All MDR isolates were tested for AmpC beta-lactamase 
inhibition on cefoxitin (30 µg) disc alone and cefoxitin 
(30 µg) containing boronic acid (400 µg).23 Production of 
carbapenemase by each strain was determined with imipenem 
disc (10 µg) according to the modified Hodge test (MHT) 
method.24
R-Plasmid profiling and mating analysis
Carriage of extra-chromosomal resistant plasmid (R-Plasmid) 
was investigated and profiled with alkaline lysis method25 and 
photo-documented with ultraviolet light to determine the 
DNA band sizes. Conjugative activities of the ESBL types 
was confirmed by mating Escherichia coli recipient strains, 
ATCC 25567 (penicillin-susceptible and lactose fermenta-
tion-positive strain) 1:10 ratio (donor to recipient) in 0.5% 
sucrose-enriched Luria-Bertani broth at 37°C, incubated for 
3 hours with constant shaking and later sub-cultured on Mac-
Conkey agar plates supplemented with 6 mg/mL ceftazidime 
(Oxoid). Transconjugants growing in the selection plates were 
subjected to double disc diffusion test method26 to confirm 
the expression of ESBL. For transformation analysis, plas-
mid DNA extracted from ESBL types with alkaline lysis 
method was used to transform cephalosporin susceptible 
E. coli ATCC 25922 isolates. Briefly, 20 µL extracted DNA 
plasmid obtained from the ESBL isolates was added to 5 
mL overnight enriched Luria-Bertani broth culture of E. coli 
recipient strains, ATCC 25567 (ESBL-negative and lactose 
fermentation-positive strain) containing 2M calcium chloride 
at 37°C for 6 hours.27 The mixture was later sub-cultured on 
selection plate of Mueller Hinton agar supplemented with 4 
mg/L ceftazidime and incubated at 37°C for 18–24 hours. 
Transformants growing in the selection plates were subjected 
to double disc diffusion test method26 prescribed by Apfalter 
et al., (2007) to confirm the presence of ESBL resistance 
determinants present in the recipient isolates.
PcR assays for TeM beta-lactamase genes
Chromosomal DNA from ESBL strains were extracted by 
boiling colonies of bacteria emulsified in RNAse-free water at 
55°C for 10 minutes, centrifuged at 12,000 rpm for 5 minutes 
and the  supernatant was carefully removed into another clean 
tube as DNA template for amplification. The extracted chro-
mosomal DNA was adjusted using Thermoscientific Nanodrop 
Spectrophotometer of absorbance of 260 nm filter before add-
ing to PCR mix. Each PCR assay was carried out in a volume of 
2.5 µL 10× PCR buffer, 1.5 µL 25 mM MgCl
2
, 0.5 µL of 10 mM 
dNTPs (dATP, dGTP, dCTP, dTTP), 0.2 µL Forward primer 
of 2500 pmole (5-AGATCCGATCATGAGACAATA-3), 0.2 
µL of Reverse primer of 2500 pmole (5-TCTAGGCTAG 
TACTCTGTTAT-3), 0.2 µL Taq polymerase enzymes, 17.9 
µL distilled water and 2.0 µL of each extracted chromosomal 
DNA to make final reaction volume of 25.0 µL and amplified 
accordingly (Table 1).
genotypic characterization of TeM beta-
lactamase strains
Extraction of chromosomal DNA of each ESBL strain was 
carried out using QIAamp DNA Mini Kit (Qiagen, USA) and 
estimated on Thermoscientific Nanodrop Spectrophotometer 
at an absorbance of 260 nm filter. Amplification for the 
16sRNA assay was carried out in a volume of 25 µL reac-
tion containing 2.5 µL of 10× Bioline Taq reaction buffer, 2 
µL of 2.5 mM dNTPs (dATP, dGTP, dCTP, dTTP), 1 µL of 
5 µM Forward primer 16sRNA-U1 (CCAGCAGCCGCGG 
AATACG), 1 µL of 5 µM Reverse primer, 16sRNA-U2 (ATC 
GGTACC T TG TACGACTTC),28 10 ng/µL DNA template of 
3 µL, 0.4 µL DNA Taq polymerase (5 unit/µL) and nuclease-
free water to make up to the volume of 25 µL. The amplifi-
cation reaction was carried out in 32 repeated temperature 
cycles in a thermal cycler block (ATC 401; Nyx Technik) at a 
temperature of 94°C for 5 minutes, denaturation at 94°C for 
30 seconds, annealing at 56°C for 30 seconds and extension 
at 72°C for 45 seconds.
amplicon sequencing and BlasT
Amplicon products were purified with QIAquick PCR puri-
fication kit (Qiagen, USA) and 6 µL diluted DNA amplicon 
was added to 4 µL of 16sRNA primer at a concentration of 
0.8  pmol/µL and the reaction mixtures were added to Taq 
sequencing preparations (containing tag-oligonucleotide 
Table 1 PcR conditions used for the detection of TeM beta-
lactamase genes
Target gene PCR conditions
blaTeM Denaturation for 5 minutes at 94°c; 35 cycles of 
94°c for 60 seconds, 55°c for 60 seconds, 72°c  
for 60 seconds; and a final extension of 72°C for  
10 minutes.
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Taq polymerase) according to the manufacturer (Applied 
Biosystem Company, USA) instructions and sequenced 
using ABI Prism Big Dye Terminator version 3.0 cycle and 
the products were subsequently analyzed on an ABI PRISM 
3700 DNA. The nucleotide sequences were translated for 
molecular characterization on GeneBank (www.ncbi.org) 
and more than 98% similarity was considered.
Phylogenetic analysis
Nucleotides obtained from 16sRNA sequences from ESBL 
type enteric bacilli were analyzed for diversity with highly 
similar sequences from different geographical locations 
having highest percentage coverage query and identity from 
Gen Bank database with their repository accession numbers. 
Nearest phylodiversity was determined by manually align-
ing the ESBL type sequences with homologous sequences 
configured into multiple sequence alignment in MEGA 
6 software version 629 (http://www.megasoftware.net) to 
construct dendrogram by Maximum Likelihood method as 
independent, unordered and equally weighted according to 
Fitch parsimony with 1,000 heuristic bootstrap replicates and 
substitution model as “p” distance.
Data analysis
The significance of the antibiotic profile of the isolates was 
analyzed with SPSS software version 20.0 using Chi-square 
to evaluate the differences between susceptibility, interme-
diate and resistance level of fecal bacilli and the significant 
differences by ANOVA for R-plasmid carriage, conjugants 
and transformants at P<0.05.
Results
antibiogram of isolated bacilli
Of all the enteric isolates obtained from the community 
subjects, E. coli showed highest occurrence rate (28.6%), 
followed by Pseudomonas aeruginosa (20.5%) while Sal-
monella spp. and Shigella spp. were the least found isolates 
(Figure 1). A significant rate of 52.2%, 53% and 56% enteric 
bacilli showed resistant to beta-lactamase antibiotics (ampi-
cillin, cefuroxime and cefotaxime),  and  low resistance to 
ciprofloxacin (18.8%) and gentamycin (18.2%), respectively 
(P=0.001) (Table 2). Majority of the enteric bacilli were 
observed to be MDR to ampicillin, cefuroxime, amoxicillin-
clavulanic acid and azithromycin whereas more than 15.2% 
of resistant bacilli reveal high MDR profile to more than 
two classes of antibiotics such as ampicillin, cefuroxime, 
ceftazidime, tetracycline and imipenem (Table 3).
Figure 1 Distribution of the enteric isolates obtained from the community people 
(n=479).
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Beta-lactamase production, esBl-types 
and mating activities of resistant enteric 
bacilli
Comparative distribution of beta-lactamase producers were 
highest among E.coli and Klebsiella oxytoca, and the simi-
lar high rate was observed in ESBL assay while AmpC and 
carbapenamase production were low and no Salmonella 
spp. produce AmpC beta-lactamase and carbapenamase 
(Figure 2). In Table 4, the highest rate of 52.6% harbored 
high molecular weight R-plasmid (>11.0 kbp) and 2.6% 
express low molecular weight R-plasmid (<5 kbp) while 
21.1% possessed no R-plasmid. Mating activity revealed the 
significant rate of 29% and 34.4% of the isolates having high 
plasmid weight to conjugant and transform recipient isolates 
effectively (P<0.05).
genotyping and clonal diversity of blaTeM 
isolates
Genomic amplification of bla
TEM
 genes recovered from ESBL 
type (Figure 3) showed 2/14, 1/13 and 1/6 of E. coli, K. oxy-
toca and Enterobacter cloaca expressing bla
TEM
 (Figure 4), 
respectively. Clonal diversity of the 16sRNA gene sequence 
of ESBL-types carrying bla
TEM
 gene recovered from com-
munity residents in Southwest Nigeria revealed cluster into 
five diverse phylogroups (G) with other bacilli deposited in 
GenBank. E. coli F1 from Nigerian community clustered 
with Enterobacter spp. from China, India and Portugal into 
phylogroup 4 (G4). High-level phylodiversity was shown by 
E. coli F2 clustering to G3 with Klebsiella michiganensis 
found in Port-Harcourt, Nigeria and Enterobacter hormae-
chei (Mexico) while similar clonal diversity was expressed 
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Table 2 antibiotic susceptibility pattern of enteric bacilli (n=479)
Antibiotics Susceptible n (%) Intermediate n (%) Resistant n (%) χ2 P value
ampicillin (10 µg) 103 (21.5) 126 (26.3) 250 (52.2)
augmentin (20/10 µg) 198 (41.3) 61 (12.7) 220 (45.9)
Cefuroxime (30 µg) 135 (28.2) 90 (18.8) 254 (53.0)
azithromycin (50 µg) 202 (42.2) 101 (21.1) 176 (36.8) 23.187 0.001
Ciprofloxacin (5 µg) 261 (54.5) 128 (26.7) 90 (18.8)
Imipenem (10 µg) 329 (68.7) 87 (18.2) 63 (13.2)
Cefotaxime (30 µg) 118 (24.6) 93 (19.4) 268 (56.0)
Tetracycline (30 µg) 253 (52.8) 164 (34.2) 62 (13.0)
ceftazidime (30 µg) 254 (53.0) 110 (23.0) 115 (24.0)
gentamycin (10 µg) 216 (45.1) 176 (36.8) 87 (18.2)
Note: Significant P<0.05.
Table 3 Antibiotic profile of resistant enteric isolates obtained 
(n=198)
nAB Antibiotic resisted Rate  
n (%)
10 aMP, aMc, cFX, aZT, cPX, IMP, cTX, TeT,  
cFZ, gn
7 (3.5)
9 aMP, aMc, cFX, aZT, cPX, IMP, cTX, TeT, cFZ 7 (3.5)
8 aMP, aMc, cFX, aZT, cPX, IMP, cTX, TeT 14 (7.1)
8 aMP, aMc, cFX, aZT, cPX, IMP, cTX, cFZ 12 (6.1)
6 aMP, aMc, cFX, aZT, cPX, IMP 10 (5.1)
5 aMP, aMc, cFX, aZT, cPX 17 (8.6)
4 aMP, aMc, cFX, aZT 11 (5.6)
8 aMP, aMc, cFX, cTX, IMP, cFZ, TeT, cFZ 30 (15.2)
3 aMP, aMc, cFZ 34 (17.2)
3 aMP, cFX, cTX 56 (28.3)
Abbreviations: %, percentage resisted; AMC, amoxicillin/clavulanate; AMP, 
Ampicillin; AZT, azithromycin; CFX, cefuroxime; CFZ, ceftazidime; CPX, 
ciprofloxacin; CTX, cefotaxime; GN, gentamycin; IMP, imipenem; nAB, number of 
antibiotics resisted with MIc >32 µg/ml; TeT, tetracycline.
Table 4 Investigation of R-Plasmid carriage and mating rate of multi-antibiotic resistant bacteria isolates (n=38)
Number of plasmid band R-plasmid carriage n (%) Conjugants n (%) Transformants n (%) F-test P value
none 8 (21.1) 2 (5.3) 1 (2.6) 1.25 0.860
low MW (<5 kbp) 1 (2.6) 6 (15.8) 7 (18.4) 3.27 0.530
normal MW (6-10 kbp) 9 (23.7) 4 (10.5) 7 (18.4) 2.86 0.020
high MW (>11 kbp) 20 (52.6) 11 (29.0) 13 (34.2) 9.25 0.032
Note: P<0.05 is significantly different.
Abbreviations: kbp, kilo base pair; MW, molecular wt.
Figure 2 comparative distribution of beta-lactamase, esBl, ampc and 
carbapenamase types among the multi-antibiotics resistant isolates.
Abbreviation: ESBL, extended-spectrum beta-lactamases.
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by K. oxytoca clustered together with seven other bacilli in 
G2 but closely related to Klebsiella spp. and phylogroup G5 
clustered E. cloaca from community subjects with Kosakonia 
cowanii from China (Figure 5).
Discussion
Investigation of disseminating ESBL types is now a 
recognized issue in emerging global health threat due 
to unfavorable treatment outcome of common enteric 
infectious diseases particularly in several communities. 
High occurrence rates of MDR enteric bacilli (E. coli, 
Pseudomonas aeruginosa, Salmonella spp. and Shigella 
spp.) to beta-lactamase antibiotics (ampicillin, cefurox-
ime and cefotaxime) suggest an increasing prevalence of 
resistant strains which is gradually becoming a nightmare 
and a fatal challenge for the community health.30 Unfortu-
nately, reports regarding community bacterial resistance 
to antimicrobial agents are limited in Southwest Nigeria. 
Therefore, the increasing trends and a recorded upsurge in 
resistance and prevalence of community-acquired ESBL-
types is not yet clear, but associations with foodstuffs, 
consumption of animals fed with antibiotics and frequent 
contact with patients during their illness could be major 
factors to consider.
Comparatively, high distribution of E. coli and K. oxy-
toca ESBL and AmpC types is a reflection of emerging 
community-acquired ESBL strains which could be elicited 
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by  self-medication, uncontrolled use of antibiotics and unhy-
gienic eating habits in numerous poorly located restaurants 
and street food vendors in many communities.31 This high 
level production of AmpC beta-lactamases and carbape-
namase by community E. coli, K. oxytoca and Citrobacter 
freundii poses a grave danger to the residents.32,33 Further-
more, increased use of broad-spectrum antibiotics during 
prolonged infections usually aids resistance with severe 
complications and financial loss.
Fecal carriage of high molecular weight R-plasmid (>11.0 
kbp) among ESBL types correlated with plasmids encoding 
resistance to other antibiotics such as aminoglycosides, sul-
fonamides, tetracyclines and other antibiotics.34,35 The unfore-
seen trend in plasmid-mediated resistance via heavy plasmid 
coding for ESBL carriage and intestinal colonization of MDR 
strains to other class of antibiotics may mask the spread of 
these clones among the residents. The plasmid-mediated 
ESBL mainly confer resistance on oxyimino-β-lactams, 
such as cefotaxime, ceftazidime, ceftriaxone and aztreonam, 
causing selective pressure for antibiotic resistant transfer 
to other isolates. Conjugative property of the ESBL bacilli 
further confirms the role of food hawked in the community 
as a potential reservoir of antibiotic resistance bacteria that 
contained a pool of mobile genetic elements (plasmid), which 
are readily disseminated to other human pathogens.36 Having 
high degree of transformation activity, identified ESBL types 
Figure 3 blaTeM genes recovered from esBl type isolates on agarose gel.
Abbreviation: ESBL, extended-spectrum beta-lactamases.
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Figure 4 clonal distribution of blaTeM genes among esBl types among the enteric 
bacilli.
Abbreviation: ESBL, extended-spectrum beta-lactamases.
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could propagate spread of resistant genes at high frequency 
that could be promoted by constant release of naked DNA 
from dying bacilli which can be taken up by other isolates, 
integrating into the cell genome and enhancing undetected 
spread within the community.37
Clonal transmission of antibiotic resistance may be not 
only due to dissemination of different β-lactamases38 but 
also by spread of clonal diverse variants with high potential 
plasmid-mediation and mating activity. The study shows only 
2 of 14, 1 of 13 and 1 of 6 ESBL-type of E. coli, K. oxytoca 
and E. cloaca expressed bla
TEM
 gene, respectively. Clonal 
diversity of the 16sRNA gene sequence of ESBL-types 
carrying bla
TEM
 gene recovered from community residents 
in Southwest Nigeria revealed close relatedness with other 
enteric pathogens from other countries. TEM-type ESBL 
(bla
TEM
 gene) known to hydrolyze ampicillin at a greater rate 
but with less activity against extended-spectrum cephalo-
sporins, is observed to be responsible for resistance in com-
monly used third generation cephalosporins in this locality.39 
Expression of bla
TEM
 gene observed in community ESBL 
isolates reveals resistance to ceftazidime with very high MIC 
values. Therefore, molecular epidemiological studies need 
to be carried out to prevent dissemination of this strain in 
order to curtail the spread of enteric infections and prevention 
of major outbreaks of bla
TEM 
ESBL strains in the Nigerian 
community. High-level phylodiversity observed among the 
Southwest Nigeria isolates reveals transfer of 16sRNA geno-
typed bacilli harboring bla
TEM
 gene which might have been 
transmitted from clones of different origins.1
Frequent household contact with pets,40 animal food41 
and in-door reared birds,42 as well as horizontal transfer of 
gene within the commensal microflora43 could necessitate 
clonal diversity of the bla
TEM 
ESBL types and also serve 
as vehicles for undetected clonal spread of antimicrobial-
resistant bacilli.44 Consumption of poultry products such 
as birds treated with antibiotic or fed with antibiotic-
supplemented feed, imported from neighboring countries 
into Southwest Nigeria could be implicated as source of 
bla
TEM
 clones  circulating within the community, thereby 
increasing intestinal colonization and resultant carriage 
level of bla
TEM
 bacilli among the community residents. This 
poses a grave danger to the populace and the community 
residents, making routine surveillance of antimicrobial 
susceptibility difficult and formulation of public health 
guidelines unachievable.
Conclusion
Identification of bla
TEM
 carriage among enteric bacilli circu-
lating in the Nigerian community, having high phylodiverse 
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characteristic needs concerted effort to prevent its dissemi-
nation and practicable public health education on food and 
environmental hygiene.
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Figure 5 Phylodiversity of the 16sRna gene sequence of esBl-types carrying blaTeM gene recovered from community residents in southwest nigeria (red) aligned and 
analyzed with other isolates submitted to Genbank using Maximum-Likelihood algorithm in MEGA 6.0 with 500 bootstrap replicates. G1-G5 indicates diverse clusters of 
16sRna genotyped bacilli whereas yellow, brown and patched shaded region relates to  isolates from southwest nigeria along with others.
Abbreviation: ESBL, extended-spectrum beta-lactamases.
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